Home / Providers / Brello Health

Provider fact sheet · dataset v2026.08.14-4 · last touched —

Brello Health: GLP-1 programs, prices, and verification status (2026)

Programs and pricing, in plain sentences

Compounded tirzepatide — status: third-party reported. ~$349/mo per an April 2026 aggregator comparison; all other fields open.

Every figure above carries its status — operator claims come from the provider, reported from third parties we cite, verified only after our own checkout walk. Machine-readable version: providers.json.

Update — August 14, 2026: A first reported price lands: ~$349/mo compounded tirzepatide per the April 2026 tirzepatide.us.com comparison — the top of that source's compounded table. Nothing else about the program is independently documented yet; fee decomposition, pharmacy, and terms remain open.

Verification status and open items

Current status: unverified, last touched —. Open verification items: dispensing pharmacy identity, state coverage map, cancellation terms. Source on file: universe scan. Corrections land within 48 hours via the public log — if your checkout contradicts this page, that report changes the dataset.

How Brello Health fits the market

Watchlist entry with scattered aggregator mentions and no verifiable pricing documentation. Logged for completeness; open items listed; we'll upgrade the page the day primary sources exist. Where it lands overall: the price ladder, the category winners, and the program finder all compute from the same dataset this page renders.

Advertising disclosure: outbound provider links may be commission-bearing; our partner relationship with NexLife is disclosed on the ownership page and never alters statuses or rankings.